ACCSYS TECHNOLOGIES PLC — Director's Dealing 2019

Jul 17, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8500F

Accsys Technologies PLC

17 July 2019

17 July 2019                                                                                                              AIM: AXS

Euronext Amsterdam: AXS

ACCSYS TECHNOLOGIES PLC

("Accsys" or "the Company")

Director Dealing

Accsys, the fast growing and sustainable chemical technology group, was notified on 16 July 2019 that Paul Hugh Anthony Clegg, Chief Executive Officer of the Company, has transferred from his brokerage account into his pension fund a total of 441,307 €0.05 ordinary shares in the Company ("Shares") at a sale price of 113.98 pence per Share.

The following notification is made under article 19 of the Market Abuse Regulation ("MAR") relating to certain transactions by persons discharging managerial responsibilities ("PDMR") in the Shares of the Company.

1.	Details of the person discharging managerial responsibilities / person closely associated
	Name	Paul Hugh Anthony Clegg
2.	Reason for the Notification
	Position/Status	The notification concerns a person discharging managerial responsibilities, being Paul Clegg, Chief Executive Officer
	Initial notification/amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Name	Accsys Technologies plc
	LEI	213800HKRFK8PNUNV581
4.	Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
	Description of the Financial instrument, type of instrument	Ordinary shares of €0.05 each in Accsys Technologies plc ("Shares")
	Identification code	GB00BQQFX454
	Nature of the Transaction	Transfer of Shares to Pension Fund from Brokerage Account by way of sale and re-purchase
	Price(s) and volume(s)	Price(s)	Volume(s)
Sale Price 113.98 pence	441,307
		Purchase Price 114 pence	441,307
	Aggregated information:	Sale Price:  £503,001.71 Purchase Price: £503,089.98
	Date of the transaction	16 July 2019
	Place of the transaction	London Stock Exchange (XLON); AIM Market

ACCSYS TECHNOLOGIES PLC 

("Accsys" of "de Vennootschap")

Regisseur Handelen

Accsys, de snelgroeiende en duurzame chemische technologie groep, is geinformeerd dat Paul Hugh Anthony Clegg, Chief Executive Officer van de Vennootschap, op 16 juli 2019 in totaal 441.307 gewone aandelen in de Vennootschap ("Aandelen") van € 0,05 per aandeel vanuit zijn effectendepot heeft overgedragen aan zijn pensioenfonds . De overdracht heeft plaatsgevonden tegen een prijs van 113,98 pence per aandeel.

De onderstaande kennisgevingen worden gedaan op grond van artikel 19 van de Market Abuse Regulation ("MAR") met betrekking tot bepaalde transacties door personen met leidinggevende verantwoordelijkheden ("PDMR") en personen die nauw met hen verbonden zijn, in aandelen van de Vennootschap.

1.	Gegevens over de persoon met leidinggevende verantwoordelijkheden / nauw verbonden persoon
	Naam	Paul Hugh Anthony Clegg
2.	Reden voor de kennisgeving
	Positie/Status	De kennisgeving betreft een persoon met leidinggevende verantwoordelijkheden, zijnde Paul Clegg, Chief Executive Officer
	Eerste kennisgeving / wijziging	Eerste kennisgeving
3.	Gegevens van de emittent, deelnemer aan de emissierechtenmarkt, veilingplatform, veilingmeester of veilingmonitor
	Naam	Accsys Technologies plc
	LEI	213800HKRFK8PNUNV581
4.	Details van de transactie (s): sectie die moet worden herhaald voor (i) elk type instrument; (ii) elk type transactie; (iii) elke datum; en (iv) elke plaats waar transacties zijn uitgevoerd
	Beschrijving van het financiële instrument, type instrument	Gewone aandelen van elk € 0,05 in Accsys Technologies plc ("aandelen")
	Identificatiecode	GB00BQQFX454
	Aard van de transactie	Aankoop van aandelen
	Prijs en volume	Prijs (pence)	Volume
Verkoopprijs 113,98	441,307
		Aankoopprijs 114,00	441,307
	Geaggregeerde informatie	Verkoopprijs:  £503,001.71 Aankoopprijs: £503,089.98
	Datum van de transactie	16 juli 2019
	Plaats van de transactie	London Stock Exchange (XLON); AIM Market

- Ends -

For further information, please contact:

Accsys Technologies PLC Paul Clegg, CEO Will Rudge, FD	via MHP Communications
Numis Securities - Nominated Adviser and Joint Broker Nominated Adviser:  Oliver Hardy Corporate Broking:   Christopher Wilkinson / Ben Stoop	+44 (0) 20 7260 1000
Investec Bank plc - Joint Broker Carlton Nelson James Rudd Alex Wright	+44 (0) 20 7597 5970
MHP Communications Tim Rowntree Kelsey Traynor	+44 (0) 20 3128 8100
Off the Grid (The Netherlands) Frank Neervoort Yvonne Derske	+31 681 734 236 +31 222 379 666

Notes to editors:

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited.  Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified.  Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Tricoya® Consortium In March 2017, Accsys announced the formation of the Tricoya® Consortium to fund, build and operate the Tricoya® plant in Hull, UK.  Members of the consortium include BP and the leading manufacturer of sustainable wood-based panels, MEDITE Europe DAC.  Tricoya Ventures UK Ltd (TVUK), a subsidiary of Accsys, owns and will operate the Tricoya® plant.  TTL exploits all Tricoya® related intellectual property and benefits from any Tricoya® related revenues other than those generated by the Tricoya® plant.  The Tricoya® plant is expected to have an initial capacity of 30,000 metric tonnes of Tricoya® chips per annum, enough to produce approximately 40,000m3 of Tricoya® panel products per annum.  The Tricoya® plant is expected to reach EBITDA breakeven at approximately 40% design capacity and to take approximately four years to reach full capacity following completion.  The location of the Tricoya® plant at Saltend Chemicals Park in Hull allows for expansion when market conditions dictate.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a higher sustainable and environmental responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited.  Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

Accsys Technologies is the trading name of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHSFLFSWFUSEEW